Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15361918 | 0.90 | HSPD1 (0.44) | HSPD1BLMHSPE1GPR84FFAR1 | |
| SCHEMBL29419065 | 0.85 | CYP3A4 (0.43) | CA2ALDH1A1HSPD1BLMHSPE1 | |
| SCHEMBL29250358 | 0.83 | ALDH1A1 (0.47) | CA2ALDH1A1HSPD1BLMHSPE1 | |
| SCHEMBL28679729 | 0.83 | HSPD1 (0.46) | HSPD1BLMHSPE1GPR84FFAR1 | |
| SCHEMBL2440934 | 0.82 | CA2 (0.46) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL11185505 | 0.82 | CA2 (0.46) | CA2ALDH1A1TSHRCYP3A4ATM | |
| Glycolic Acid SCHEMBL3075595 | 0.82 | ALDH1A1 (0.46) | CA2ALDH1A1HSPD1BLMHSPE1 | |
| SCHEMBL4969138 | 0.82 | ALDH1A1 (0.45) | CA2ALDH1A1HSPD1BLMHSPE1 | |
| SCHEMBL27559046 | 0.81 | CA2 (0.42) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL2902801 | 0.81 | CA2 (0.45) | CA2ALDH1A1TSHRCYP3A4ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3344220-B1 | MICROCAPSULES ENCAPSULATING A REFLECTIVE AGENT | TAGRA BIOTECHNOLOGIES LTD (IL) | 2024-05-08 | — | — | EP | claimed |
| EP-3784706-B1 | PREPARATION OF AN ACTIVE POLYMER EMULSION | COATEX SAS (FR) | 2024-04-03 | — | — | EP | claimed |
| US-9956147-B2 | Emulsion containing a dispersion of bismuth oxychloride | L'OREAL (FR) | 2018-05-01 | — | — | US | claimed |
| EP-2826460-B1 | Emulsion containing a dispersion of bismuth oxychloride | OREAL (FR) | 2017-08-23 | — | — | EP | claimed |
| EP-2456413-B1 | EMULSION CONTAINING A BISMUTH OXYCHLORIDE DISPERSION | L'ORÉAL (FR) | 2017-06-21 | — | — | EP | claimed |
| EP-2804670-B1 | COSMETIC COMPOSITION COMPRISING ENCAPSULATED PIGMENTS AND REFLECTIVE PARTICLES PREDISPERSED IN AN OIL | OREAL (FR) | 2017-06-14 | — | — | EP | claimed |
| US-20170014319-A1 | EMULSION CONTAINING A DISPERSION OF BISMUTH OXYCHLORIDE | L'ORÉAL (FR) | 2017-01-19 | — | — | US | claimed |
| EP-2826459-B1 | Emulsion containing a dispersion of bismuth oxychloride | OREAL (FR) | 2016-09-21 | — | — | EP | claimed |
| EP-2345401-B1 | Use of volatile linear alkanes and liquid fatty esters in an anhydrous medium for cosmetic treatment of keratin fibres, and anhydrous cosmetic composition of volatile linear alkanes, liquid fatty esters and specific oils. | ORÉAL L (FR) | 2015-07-22 | — | — | EP | claimed |
| EP-1614411-B1 | OILY MAKEUP COSMETICS | KANEBO COSMETICS INC (JP) | 2011-10-05 | — | — | EP | claimed |
| US-20070122508-A1 | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | HELIXIR CO., LTD. (KR) | 2007-05-31 | — | — | US | claimed |
| US-20230127213-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF SKIN ULCER AND THE USE THEREOF | PARK, OK NAM (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230103514-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE SKIN REGENERATION AND THE TREATMENT OR ALLEVIATION OF SKIN WOUND AND THE USE THEREOF | MEDIHELPLINE CO., LTD (KR) | 2023-04-06 | — | — | US | disclosed |
| US-20230100173-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR TLSP INHIBITION AND THE TREATMENT OR ALLEVIATION OF SKIN INFLAMMATORY DISEASE AND THE USE THEREOF | MEDIHELPLINE CO., LTD (KR) | 2023-03-30 | — | — | US | disclosed |
| EP-4117698-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE SKIN REGENERATION AND THE TREATMENT OR ALLEVIATION OF SKIN WOUND AND THE USE THEREOF | Medihelpline Co., Ltd. (KR) | 2023-01-18 | — | — | EP | disclosed |
| EP-1551433-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA AND RELATED SPECIES FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE AND NON-ALLERGIC INFLAMMATORY DISEASE | Pangenomics Co., Ltd. (KR) | 2005-07-13 | — | — | EP | disclosed |
| WO-2004096171-A1 | SKIN WHITENING COSMETIC COMPOSITION COMPRISING THE EXTRACT OF MACHILUS THUNBERGII AND THE COMPOUNDS ISOLATED THEREFROM | YEUNGNAM EDUCATIONAL FOUNDATION (KR) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004072498-A1 | OIL IMPREGNATED SINTERED BEARING | HITACHI POWDERED METALS CO., LTD. (JP) | 2004-08-26 | — | — | WO | disclosed |
| WO-2004017982-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA AND RELATED SPECIES FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE AND NON-ALLERGIC INFLAMMATORY DISEASE | PANGENOMICS CO., LTD (KR) | 2004-03-04 | — | — | WO | disclosed |
| US-20040037909-A1 | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | VIROMED CO., LTD. (KR) | 2004-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170014319-A1 | EMULSION CONTAINING A DISPERSION OF BISMUTH OXYCHLORIDE | KRT18, NR1H4, MKI67 | CA2 675/4885ALDH1A1 1380/4885HSPD1 1489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.